FineHeart Receives ANSM1 Authorization to Deploy Its First-In-Human Clinical Study in France
FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) to initiate its First-In-Human (FIH) clinical trial in France.
This prospective, non-randomized study is designed to assess the safety, implant feasibility and preliminary clinical performance of the FlowMaker® device in patients with advanced heart failure. It follows the first successful implantations carried out in 2024 at IKEM ( Institute for Clinical and Experimental Medicine ) in Prague, whose initial results have been presented at several international scientific congresses.
Conducted in several French centers specializing in cardiac surgery, this study represents a decisive step in the clinical development of FlowMaker®.
FlowMaker® is a new-generation, fully implantable left ventricular assist device designed to work in synergy with the heart's natural contraction. Less invasive than current devices, this technology aims to preserve native cardiac function while significantly improving patients' quality of life.
Pr Pascal Leprince, Head of the Thoracic and Cardiovascular Surgery Department at Hôpital Universitaire Pitié-Salpêtrière (AP-HP) Sorbonne Université and principal investigator of the clinical trial in France, commented: " The launch of this trial in France represents a highly promising step forward for patients with advanced heart failure. Thanks to its pulsatile operation, synchronized with the heart's electrical activity, the FlowMaker® could transform the treatment of these patients, offering them a less invasive and potentially more durable solution than current devices. We look forward to starting this clinical study and confirming these benefits.'1ANSM: French National Agency for the Safety of Medicines and Health Products
About FineHeart -FineHeart
View source version on businesswire.com:https://www.businesswire.com/news/home/20250603183502/en/
CONTACT: Europe
Media Relations
Annie-Florence Loyer
[email protected]
+33 (6) 88 20 35 59FineHeart Communications
James Palmer
[email protected]
+33 (0) 7 60 92 77 72
KEYWORD: EUROPE CZECH REPUBLIC FRANCE
INDUSTRY KEYWORD: MEDICAL DEVICES OTHER HEALTH HEALTH CLINICAL TRIALS CARDIOLOGY
SOURCE: FineHeart S.A.
Copyright Business Wire 2025.
PUB: 06/03/2025 07:01 AM/DISC: 06/03/2025 07:01 AM
http://www.businesswire.com/news/home/20250603183502/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
OCEU/CUPE 1750 Members Vote Yes to Ratify Tentative Agreement
TORONTO--(BUSINESS WIRE)--The Ontario Compensation Employees Union (OCEU/CUPE 1750) is pleased to announce that its members have voted to accept the tentative collective agreement negotiated by their bargaining committee. The union remains concerned about the ongoing anti-union measures being pursued by the Ford Government and will remain vigilant in defending workers' rights and fair bargaining processes. Share 'I am proud of my coworkers and the strength of our union, we are a critical safety net for Ontario workers and Ontarians spoke up, sending thousands of messages to the WSIB leadership,' said Harry Goslin, President of OCEU/CUPE 1750. 'Together, we were able to secure the best possible outcome and successfully pushed back against the employer's attacks on union seniority rights.' This strike was a historic moment for our union and the broader labour movement. We thank our members for their unwavering commitment and courage, the public for their understanding, and our fellow unions for their solidarity and support throughout this challenging fight. As members prepare to return to work on Monday, July 7, 2025, the union remains steadfast in its commitment to protect workers' rights and health. OCEU/CUPE 1750 will continue to stand in solidarity with other public sector unions currently negotiating collective agreements. The union remains concerned about the ongoing anti-union measures being pursued by the Ford Government and will remain vigilant in defending workers' rights and fair bargaining processes. mb/cope491
Business Insider
2 hours ago
- Business Insider
Genesis AI Raises $105M to Train Robotics AI Aiming at $30T Labor Market
Genesis AI, a private company, has raised $105 million in seed funding to develop a universal robotics foundation model (RFM) designed to automate physical labor across industries. The round was co-led by Eclipse Ventures and Khosla Ventures, with participation from Bpifrance, HSG, and notable investors including former Google (GOOG) CEO Eric Schmidt and French billionaire Xavier Niel. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. The company, founded in December 2024, operates out of Palo Alto and Paris. Its co-founders are Zhou Xian, a Carnegie Mellon robotics Ph.D. holder, and Théophile Gervet, a former researcher at Mistral AI. Genesis Aims for Full Stack Approach Genesis AI's core product is a large-scale model designed to equip robots with the ability to handle a wide range of real-world tasks. Its in-house physics simulation engine generates high-quality synthetic data, reducing the need for expensive and time-consuming real-world data collection. Combined with a data pipeline for real robot interactions, the company claims it can build robotics AI systems faster and more cost-effectively than competitors relying on third-party tools. The goal is to bring general-purpose robotics closer to reality by making it more flexible, robust, and cost-efficient. Genesis AI plans to release components of its model and data engine to the developer community by the end of 2025. $30 Trillion to $40 Trillion in Global GDP According to the company, over 95% of physical labor worldwide remains unautomated, despite accounting for an estimated $30 trillion to $40 trillion in global GDP. Genesis AI is targeting this opportunity with a full-stack approach that spans simulation, generative modeling, and real-world deployment. While competitors like Tesla (TSLA) and Nvidia (NVDA) focus on hardware or modular platforms, Genesis AI is betting that foundation models will define the next phase of robotics. If successful, its platform could support a range of use cases, from warehouse operations to consumer robots. Using TipRanks' comparison tool, we've assembled and compared the tickers appearing in the piece that operate in the robotics sector. This helps investors gain a proper perspective on each stock's performance and the industry as a whole.
Chicago Tribune
6 hours ago
- Chicago Tribune
US tariffs on European goods threaten to shake up the world's largest trade relationship
FRANKFURT, Germany — The European Union expects to find out on Monday whether President Donald Trump will impose punishing tariffs on America's largest trade partner in a move economists have warned would have repercussions for companies and consumers on both sides of the Atlantic. Trump imposed a 20% import tax on all EU-made products in early April as part of a set of tariffs targeting countries with which the United States has a trade imbalance. Hours after the nation-specific duties took effect, he put them on hold until July 9 at a standard rate of 10% to quiet financial markets and allow time for negotiations. Expressing displeasure the EU's stance in trade talks, however, Trump said he would increase the tariff rate for European exports to 50%, which could make everything — from French cheese and Italian leather goods to German electronics and Spanish pharmaceuticals — much more expensive in the U.S. The EU's executive commission, which handles trade issues for the bloc's 27-member nations, said its leaders hope to strike a deal with the Trump administration. Without one, the EU said it was prepared to retaliate with tariffs on hundreds of American products, ranging from beef and auto parts to beer and Boeing airplanes. U.S. Treasury Secretary Scott Bessent told CNN's 'State of the Union' program on Sunday that 'the EU was very slow in coming to the table' but that talks were now making 'very good progress.' Here are important things to know about trade between the United States and the European Union. The EU's executive commission describes the trade between the U.S. and the EU as 'the most important commercial relationship in the world.' The value of EU-U.S. trade in goods and services amounted to 1.7 trillion euros ($2 trillion) in 2024, or an average of 4.6 billion euros a day, according to EU statistics agency Eurostat. The biggest U.S. export to Europe is crude oil, followed by pharmaceuticals, aircraft, automobiles, and medical and diagnostic equipment. Europe's biggest exports to the U.S. are pharmaceuticals, cars, aircraft, chemicals, medical instruments, and wine and spirits. Trump has complained about the EU's 198 billion-euro trade surplus in goods, which shows Americans buy more stuff from European businesses than the other way around. However, American companies fill some of the gap by outselling the EU when it comes to services such as cloud computing, travel bookings, and legal and financial services. The U.S. services surplus took the nation's trade deficit with the EU down to 50 billion euros ($59 billion), which represents less than 3% of overall U.S.-EU trade. Before Trump returned to office, the U.S. and the EU maintained a generally cooperative trade relationship and low tariff levels on both sides. The U.S. rate averaged 1.47% for European goods, while the EU's averaged 1.35% for American products. But the White House has taken a much less friendly posture toward the longstanding U.S. ally since February. Along with the fluctuating tariff rate on European goods Trump has floated, the EU has been subject to his administration's 50% tariff on steel and aluminum and a 25% tax on imported automobiles and parts. Trump administration officials have raised a slew of issues they want to see addressed, including agricultural barriers such as EU health regulations that include bans on chlorine-washed chicken and hormone-treated beef. Trump has also criticized Europe's value-added taxes, which EU countries levy at the point of sale this year at rates of 17% to 27%. But many economists see VAT as trade-neutral since they apply to domestic goods and services as well as imported ones. Because national governments set the taxes through legislation, the EU has said they aren't on the table during trade negotiations. 'On the thorny issues of regulations, consumer standards and taxes, the EU and its member states cannot give much ground,' Holger Schmieding, chief economist at Germany's Berenberg bank, said. 'They cannot change the way they run the EU's vast internal market according to U.S. demands, which are often rooted in a faulty understanding of how the EU works.' Economists and companies say higher tariffs will mean higher prices for U.S. consumers on imported goods. Importers must decide how much of the extra tax costs to absorb through lower profits and how much to pass on to customers. Mercedes-Benz dealers in the U.S. have said they are holding the line on 2025 model year prices 'until further notice.' The German automaker has a partial tariff shield because it makes 35% of the Mercedes-Benz vehicles sold in the U.S. in Tuscaloosa, Alabama, but the company said it expects prices to undergo 'significant increases' in coming years. Simon Hunt, CEO of Italian wine and spirits producer Campari Group, told investment analysts that prices could increase for some products or stay the same depending what rival companies do. If competitors raise prices, the company might decide to hold its prices on Skyy vodka or Aperol aperitif to gain market share, Hunt said. Trump has argued that making it more difficult for foreign companies to sell in the U.S. is a way to stimulate a revival of American manufacturing. Many companies have dismissed the idea or said it would take years to yield positive economic benefits. However, some corporations have proved willing to shift some production stateside. France-based luxury group LVMH, whose brands include Tiffany & Co., Luis Vuitton, Christian Dior and Moet & Chandon, could move some production to the United States, billionaire CEO Bernaud Arnault said at the company's annual meeting in April. Arnault, who attended Trump's inauguration, has urged Europe to reach a deal based on reciprocal concessions. 'If we end up with high tariffs, … we will be forced to increase our U.S.-based production to avoid tariffs,' Arnault said. 'And if Europe fails to negotiate intelligently, that will be the consequence for many companies. … It will be the fault of Brussels, if it comes to that.' Some forecasts indicate the U.S. economy would be more at risk if the negotiations fail. Without a deal, the EU would lose 0.3% of its gross domestic product and U.S. GDP would fall 0.7%, if Trump slaps imported goods from Europe with tariffs of 10% to 25%, according to a research review by Bruegel, a think tank in Brussels. Given the complexity of some of the issues, the two sides may arrive only at a framework deal before Wednesday's deadline. That would likely leave a 10% base tariff, as well as the auto, steel and aluminum tariffs in place until details of a formal trade agreement are ironed out. The most likely outcome of the trade talks is that 'the U.S. will agree to deals in which it takes back its worst threats of 'retaliatory' tariffs well beyond 10%,' Schmieding said. 'However, the road to get there could be rocky.' The U.S. offering exemptions for some goods might smooth the path to a deal. The EU could offer to ease some regulations that the White House views as trade barriers. 'While Trump might be able to sell such an outcome as a 'win' for him, the ultimate victims of his protectionism would, of course, be mostly the U.S. consumers,' Schmieding said.
